Drug Development and Registration
SJR0.189
RU
RUJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.189 | Q3 | 25.6% | |
| 2024 | — | — | 0.168 | Q3 | 24.3% | |
| 2023 | — | — | 0.187 | Q3 | 32.7% | |
| 2022 | — | — | 0.191 | Q3 | 36.0% | |
| 2021 | — | — | 0.156 | Q3 | 31.7% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2305-2066
ISSN
2658-5049
country
RUcoverage
2019-2025